Abstract
Prokaryotic and archaeal chromosomes encode a diversity of toxin–antitoxin (TA) systems that contribute to a variety of stress-induced cellular processes in addition to stability and maintenance of mobile elements. Here, we find DinJ-YafQ family TA systems to be broadly distributed amongst diverse phyla, consistent with other ParE/RelE superfamily TAs, but more unusually occurring as a multiplicity of species-specific subtypes. In the gastric pathogen Helicobacter pylori we identify six distinct subtypes, of which three are predominantly associated with the mobilome, including the disease-associated integrative and conjugative element (ICE), tfs4. Whereas, the ICE-encoded proteins have characteristic features of DinJ-YafQ family Type II TA systems in general, the toxin component is distinguished by a broad metal-ion-dependent endonuclease activity with specificity for both RNA and DNA. We show that the remarkably rapid growth inhibitory activity of the ICE toxin is a correlate of a C-terminal lysine doublet which likely augments catalytic activity by increasing the positive electrostatic potential in the vicinity of the conserved active site. Our collective results reveal a structural feature of an ICE TA toxin that influences substrate catalysis and toxin function which may be relevant to specific TA-mediated responses in diverse genera of bacteria.
Subject terms: Biochemistry, Biological techniques, Microbiology, Molecular biology, Pathogenesis
Introduction
Toxin–antitoxin systems are virtually ubiquitous amongst bacteria and archaea and commonly encoded on plasmids and bacteriophages from which they can be disseminated, acquired and stably integrated into host chromosomes1–4. They were first revealed to play a role in plasmid maintenance2, however, chromosomally-encoded TA systems in particular are now recognised to have numerous important physiological roles which promote bacterial survival, including formation of a persister state, inhibition of bacteriophage, regulation of stress responses, biofilm formation and pathogenesis5–11.
Currently, seven distinct classes of TA system (Types I–VII) have been described based on the mechanism by which the antitoxin inhibits the activity of the toxin12,13. Whereas, the toxins associated with all classes tends to be proteins, the antitoxin is either also a protein (Types II, IV–VII) or a non-coding RNA (Types I and III). As a common mechanistic theme, the toxin of each TA pair causes growth arrest by interference with a critical cellular process in response to a particular environmental stress or vulnerability (e.g. viral predation) but is otherwise inhibited by antitoxin during normal growth. Liberation of toxin activity from antitoxin repression occurs as a consequence of the selective stress-induced degradation of the intrinsically more unstable antitoxin component12.
Type II TA systems, in which the toxin is inhibited by direct protein–protein interaction with the antitoxin, are particularly abundant and are represented by numerous conserved families including RelBE, CcdAB, YefM-YoeB, DinJ-YafQ, MazEF and ParDE14–18. Type II toxins tend to be endoribonucleases (RNases) which inhibit translation by related, but distinct mechanisms. These involve ribosome-dependent18–20 or independent cleavage of mRNA21 or the inhibition of ribosome-associated factors22, although exceptionally, ParDE family toxins inhibit replication by interference with DNA gyrase function16.
In the DinJ-YafQ system, the YafQ toxin is a ribosome-associating endoribonuclease in vivo which also exerts potent ribosome-independent cleavage activity in vitro18. Structural and mutagenesis studies have defined specific residues of YafQ important for toxicity, many of which are required for substrate recognition, binding and catalysis19,23. These include several active site histidine residues, His50, His63, His87 in addition to Asp67, Phe91 and a subset of positively charged, mainly lysine residues, which comprise extended basic surface patches19. The catalytic residues in particular are highly conserved between YafQ and two structurally homologous endoribonuclease TA toxins, HP0892 and HP0894 of Helicobacter pylori24–27. Four different Type II TA systems have been described so far in H. pylori, HP0892-HP0893, HP0894-HP0895, HP0315-HP0316 and HP0968-HP0967, the latter two comprising toxins of the virulence-associated protein family, VapD28,29.
H. pylori is a clinically important member of the Epsilon-proteobacteria which persistently colonises the gastric mucosa of ~ 50% of the World’s population. Although most colonised individuals remain asymptomatic, infection is a significant risk factor for several gastrointestinal diseases, including peptic ulcer disease and gastric cancer, the third leading cause of cancer-related deaths worldwide30,31. Disease susceptibility is considered to be multifactorial, involving a complex interplay between multiple environmental, host and bacterial factors. Of the latter, several well characterised virulence factors of H. pylori are known to contribute to the pathogenic potential of different H. pylori strains32–34 and more recently, components encoded on each of two variably present integrative and conjugative elements (ICEs) termed tfs3 and tfs4 have also emerged as potentially important in the host pathogen interaction35–38. ICEs are widespread amongst bacteria and commonly confer attributes such as resistance to antibiotics or new metabolic or virulence functions which increase fitness, genetic diversity and drive evolutionary change. ICEs also encode for conserved core activities which enable their chromosomal integration, excision and transfer to a recipient cell. When integrated, ICEs are stably maintained and replicated together with the host chromosome but are susceptible to loss if excision coincides with cell division39. However, similar to plasmids, ICEs also encode factors, including TA systems, which function to reduce the incidence of ICE-free daughter cells39,40.
In this study, we determine that DinJ-YafQ family TA systems are highly prevalent in prokaryotic genomes and unusually diversified into multiple species-specific subtypes. In H. pylori, we identify the variable presence of six distinct subtypes which includes HP0892-HP0893, HP0894-HP0895 in addition to three TAs encoded by either plasmids or the tfs4 ICE. Focusing on the ICE TA system, we show that the associated toxin is structurally homologous to the chromosomal toxins HP0892 and HP0894, and although similar with respect to endoribonuclease activity, has a broader substrate range which includes both RNA and DNA. Moreover, the ICE toxin exerts a rapid and potent growth inhibitory activity relative to the other TA toxins which we determine is a correlate of a double lysine extension at the C-terminus of the protein. This appears to extend the surface area and positive electrostatic potential in the vicinity of the active site for recruitment of nucleic acid substrates, revealing a novel structure–function adaptation that efficiently modulates TA toxin activity.
Results
The tfs4 ICE TA is a distinct subtype of the DinJ-YafQ-family
Up to five Type II TA systems have been identified in H. pylori29 of which two, HP0892–HP0893 and HP0894–HP0895 are members of the DinJ-YafQ family24,25. In a survey of tfs ICE content38, we identified a third putative DinJ-YafQ system suggesting that this family is particularly well-represented in H. pylori strains. Since the distribution and abundance of TA systems varies widely due to a tendency for both frequent horizontal gene transfer and intragenomic recombination1, 4 we were interested to assess the distribution of these modules relative to each other in the H. pylori population.
For this, the putative ICE toxin sequence was initially used as query in a series of BLASTp searches to compile a dataset of 707 H. pylori consensus sequences from a total of 7,568 multispecies BLASTp subject hits. Surprisingly, subsequent phylogenetic analyses identified a total of six distinct clades (T1–T6) of H. pylori proteins nested within the YafQ-family of Type II TA toxins (Supplementary Fig. S1a, Fig. 1a left), and a similar multiplicity of related, but species-specific toxins from multiple different phyla indicating the YafQ family to be unusually diverse (Supplementary File S1). Associated antitoxin sequences produced a similar tree topology of major clades (AT1–6) nested within the DinJ antitoxin family (Supplementary Fig. S1a, Fig. 1a right). Antitoxin sequences associated with the vapD locus, encoding the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) associated Cas2-like VapD protein and a Type II TA antitoxin28 were similarly identified within the DinJ family clustering with AT1, AT2 or AT5 Clades, whereas unrelated vapD sequences (represented by HP0315) formed an outgroup to the YafQ-like toxins as expected. The vapD locus is considered to be a hybrid or intermediate TA-like system, however, we found the vapD gene to be frequently flanked by a conserved partial sequence common to all six YafQ toxin clades, suggesting that the HP0315-homologous vapD gene is a likely foreign insertion into particular yafQ loci.
Two TA clades associated with H. pylori plasmids (Clades T4/AT4 and T6/AT6) were also apparent in the genomes of the phylogenetically-related Helicobacter acinonychis and Helicobacter cetorum strains but no other Helicobacter species, although surprisingly homologous sequences (> 94% nucleotide sequence identity) were also detected in the Bacteroidetes bacterium Muricauda olearia and a plasmid from four strains of the Firmicute Staphylococcus pseudintermedius (Supplementary Fig. S1b) suggesting recent cross-phyla exchange of these particular TA modules.
We next searched the PATRIC database to examine the relative distribution of each TA subtype within a geographically diverse collection of 721 genome sequenced H. pylori strains. Either or both ICE Clade T3/AT3 sequences were found in a total of 393 genomes and of these, the intact ICE TA module was present in 366 (93%), which was broadly comparable with the prevalence/integrity of Clade T1/AT1 and T2/AT2 TA sequences (326/86% and 324/79% respectively). Clade T4/AT4 TAs were also abundant in these genomes but more frequently inactivated by mutational attrition of the toxin gene (347/55%). This was similarly the case for the least abundant Clade T6/AT6 and T5/AT5 TA sequences (85/52% and 160/55% respectively) (Fig. 1b). We found no correlation between distribution and co-residence of the different TA modules in either the presence (Fig. 1b, top panel) or absence of the ICE TA loci (Fig. 1b bottom panel) suggesting that activity of neither plasmid nor genomic TA systems are likely to be restrictive of ICE acquisition.
The tfs4 ICE encodes a functional Type II TA module
In view of the evident conservation of the Clade T3/AT3 ICE modules within the H. pylori population we chose to investigate the tfs4 TA locus further. Common to other Type II TA module proteins, both the ICE toxin and antitoxin proteins share physical properties of predicted overall charge and small size (MW 10.9 kDa/pI 9.1 and MW 12.2 kDa/pI 5.9 respectively), and are encoded by overlapping genes in an apparent bicistron located centrally within the tfs4 ICE (Fig. 2a). In an initial investigation of the TA locus, we expressed the toxin, referred to here as ‘TfiT’ (tfs-four ICE toxin) for brevity, from the arabinose inducible pBAD18 plasmid using a selection of Escherichia coli strains as model hosts. In all cases, we observed a rapid post-induction reduction in growth along with a sharp decline in colony forming units (CFU ml−1) (Fig. 2b) consistent with TA toxin function. In contrast, no growth inhibitory activity was observed following similar expression of the putative antitoxin, ‘TfiA’ (tfs-four ICE antitoxin).
To examine if TfiA could inhibit TfiT activity, the entire encoding bicistron was engineered into the dual expression vector pACYCDuet-1 to enable both proteins to be epitope-tagged and co-expressed in the genetic context of the module. In this arrangement, TfiT toxicity was completely inhibited in the presence of TfiA (Fig. 2b), although it was notable that yields of the tagged proteins were not equivalent (Fig. 2c). We were unable to transform a control pACYCDUET-TfiT construct in these experiments, presumably due to leaky expression, therefore to confirm TfiA activity, we employed an alternative co-expression strategy in which delayed induction of TfiA (expressed from pACYCDuet-1 following induction on IPTG plates) was demonstrated to rescue cells from extended exposure to TfiT (expressed from pBAD18 in broth as before), whereas in the absence of antitoxin, TfiT-exposed cells were non-viable and could not be recovered (Supplementary Fig. S2). These results indicate that TfiT toxin activity is bacteriostatic and can be rescued in the presence of TfiA.
Since ICEs have both integrated and extrachromosomal states39, we next investigated the ability of the TA module to stabilise and maintain an extrachromosomal element. For this, we inserted the entire TA module without (F0) or with the inclusion of either a large (F1, 213 bp) or smaller (F2, 160 bp) stretch of upstream flanking sequence into the high copy number pUC18 plasmid. Sequential daily passage of plasmids without antibiotic selection in E. coli MG6155 showed complete retention of both F1/F2 TA-containing plasmids compared with a steady loss observed for the parent or F0 plasmids (Fig. 2d). These results demonstrate that functional activity of the ICE TA in vivo is sufficient to stably maintain an extrachromosomal element and moreover that TA expression is controlled by a native TA module promotor. In support of this latter observation, a promotor region comprising − 35 and − 10 boxes (sequences TTTTTT and GGCTATAAT respectively) is predicted to be within the first 65 bp of the antitoxin start codon in strain H. pylori P12.
Finally, as inhibition of toxin activity is mediated by direct interaction between toxin and antitoxin proteins in Type II TA systems12,41 we next assessed the ability of recombinant TfiT to capture and co-purify TfiA in a pulldown assay. For this, C-terminal His-tagged TfiT was immobilised on TALON metal affinity resin prior to incubation with lysate containing C-terminal S-tagged TfiA. Subsequent Western immunoblotting of test and control elution fractions showed that co-purification of TfiA was entirely dependent upon the presence of TfiA (Fig. 2e). In support of this observation, a Far Western approach using purified TfiT as a probe similarly showed specific binding to TfiA contained within a bacterial lysate (Fig. 2f). As final confirmation of the interaction, we used a series of yeast two-hybrid assays which showed a stable reciprocal pairwise interaction between TfiT and TfiA proteins and moreover, indicated a strong propensity for TfiA dimerization (Table 1).
Table 1.
Baita | TfiA | TfiT | |
---|---|---|---|
Preyb | TfiA | TfiT | TfiA |
−His/−Adec | +++ | +++ | +++ |
−Hisc | +++ | +++ | +++ |
lacZd (Miller UNITS) | 128.7 ± 8.6 | 60.8 ± 5.9 | 89.8 ± 7.4 |
lacZd (fold increase)e | 27.4 | 12.9 | 47.2 |
aBait and bprey fusions were constructed in pGBT9 and pGAD424 vectors respectively.
cYMM plates were supplemented with Met and uracil and lacked either His, or both His and Ade as indicated.
dlacZ reporter activity was assessed by β-galactosidase assay.
eFold increase relative to self-activation control for each bait vector.
Collectively, these results indicate that TfiA is the cognate antitoxin of TfiT and that TfiA–TfiT have features typical of other Type II TA systems.
TfiT is a metal-ion-dependent endonuclease
The H. pylori HP0892 and HP0894 Type II toxins are endoribonucleases which cleave mRNA with limited sequence specificity24,25. We therefore next sought to determine if TfiT similarly exhibited RNase activity by performing mRNA cleavage assays with purified His-tagged TfiT (0–16 uM). Results showed equivalent concentration-dependent degradation of two unrelated in vitro synthesised mRNA templates, recA (Fig. 3a) and tfiT (Supplementary Fig. S3a) consistent with endoribonuclease activity. To confirm the specificity of this activity towards RNA, we examined the ability of TfiT to degrade a variety of other nucleic acid substrates. However, contrary to expectation, TfiT demonstrated a similar concentration-dependent activity towards both genomic and plasmid DNA (Fig. 3b,c respectively) which was not apparent following pre-treatment of TfiT with Proteinase K (Supplementary Fig. S3b). With respect to plasmid, increasing concentration of TfiT showed a progressive conversion of supercoiled plasmid to relaxed and linear forms prior to more substantial degradation (Fig. 3c) consistent with single-stranded nicking activity. Notably, very low concentrations of TfiT (< 0.25 µM) were required for initial plasmid relaxation (Supplementary Fig. S3c). All observed nuclease activity of TfiT was dependent upon the presence of divalent cation (Mg2+), although Mg2+ could be effectively substituted by Mn2+, with a concomitant two to fourfold potentiation of nuclease activity. Other common cofactors of catalytic activity, Cu2+, Zn2+, Ni2+ and Ca2+ were found to be either suppressive or unable to promote TfiT nicking activity in vitro (Fig. 3d).
The uniform fragmentation observed for both genomic and plasmid DNA at higher concentrations of TfiT (Fig. 3b,c) suggests that TfiT activity also has low sequence specificity. To explore this, we developed a protocol to precisely determine the nick site of TfiT-cleaved DNA template. As the substrate with the greatest complexity of sequence, genomic DNA was treated with TfiT to produce ~ 100–3,000 kbp fragments, then on the assumption that coincident nicking on both strands would frequently generate blunt cleavage products, fragments were A-tailed, cloned and sequenced. Insert sequences from 30 transformant colonies were subsequently mapped to the reference genome sequence, from which we unambiguously determined the cleavage context at 42 unique insert ends (Supplementary File S2). Comparative analysis of nick site sequences however failed to identify any sequence consensus other than a slightly increased frequency of guanine and cytosine at the nick site (Fig. 3e), confirming our initial observations that TfiT nicking/cleavage activity has low or no sequence specificity.
TfiT toxicity and catalysis are potentiated by C-terminal lysines
All six clades of H. pylori YafQ-family toxins show good conservation of sequence motifs including several active site residues within the C-terminal motif His/Ser/Glu/Leu/Phe (HSELF) (Fig. 4a,b) which are similarly well conserved in YafQ-family toxins from other diverse genera (Fig. 4c, Supplementary File S1). The His residue in particular (H87, H86, H84 of YafQ, HP0892 and HP0894 respectively) is a key catalytic residue, which together with the other HSELF residues comprise one of three clusters in the active site that are essential for recognition and binding of nucleotides23,25,42.
As the ‘HSELF’ motif is equally well conserved in TfiT, we constructed a series of C-terminal mutants including H87L and ΔHSELFKK (TfiTΔ87–93) to assess the functional homology of this motif. A further mutant, ΔKK (TfiTΔ92–93) was also included to investigate the contribution of the terminal lysine pair of TfiT, as this extension is distinctive of both the H. pylori Clade T3 ICE toxin and particular YafQ subtypes present in other genera (Fig. 4c, Supplementary File S1).
As observed for equivalent mutation of HP089425, substitution of TfiT H87 markedly reduced, although did not entirely abolish RNase and growth inhibitory activity, whereas deletion of the entire TfiT C-terminal HSELFKK motif resulted in complete abrogation of all catalytic activity (Fig. 5a,b respectively). To verify the structural integrity of the TfiTΔ87-93 (HSELFKK) mutant protein, a column pulldown (Supplementary Fig. S4) and yeast two-hybrid assay (Supplementary Table S4) showed that C-terminal deletion did not compromise the stability or ability of recombinant TfiTΔ87-93 to interact with TfiA antitoxin.
Remarkably, deletion of the C-terminal lysine doublet in TfiTΔ92–93 was also seen to markedly decrease the toxicity of TfiT, reflected by a ~ 104-fold initial increase in the viability (CFU ml−1) of TfiTΔ92-93 intoxicated cells, and also significantly delay its onset (Fig. 5a). Although less pronounced, a concomitant fold reduction in nuclease activity of the TfiTΔ92–93 mutant compared to wildtype TfiT was also apparent (Fig. 5b). These results therefore suggest that the presence of the C-terminal lysines enhances the activity of the wildtype ICE toxin.
To explore this further, we engineered an equivalent lysine doublet at the C-terminus of the Clade T2 and T1 genomic toxins HP0892 and HP0894, generating HP0892KK and HP0894KK, and repeated growth experiments as before. Consistently, both wildtype HP0892 and HP0894 toxins, which naturally lack the lysine doublet (Fig. 4a), displayed a closely similar growth arrest phenotype as the TfiTΔ92-93 lysine mutant (Fig. 5c, Supplementary Fig. S5a), whereas addition of the lysine doublet to HP0894 increased its growth inhibitory activity to a level comparable with wildtype TfiT. The effect of the lysine doublet on HP0892 however was substantially more pronounced, incurring an almost immediate inhibition of growth and a > 103-fold reduction in viability (CFU ml−1) of HP0892KK intoxicated cells within the first 30 min of induction relative to TfiT (Fig. 5c, Supplementary Fig. S5a). Compared to the more modest increases observed for TfiT and HP0894KK, the HP0892KK mutant also showed a > twofold potentiation of RNase activity relative to the wildtype toxin, confirming the overall enhanced effect (Fig. 5b,d, Supplementary Fig. S6).
Of additional note, whereas both HP0892 and HP0894 demonstrated some nicking of plasmid DNA, neither wildtype toxin, which were of similar purity and concentration as TfiT (Supplementary Fig. S5b) showed any discernible nuclease activity towards genomic DNA (Supplementary Fig. S5c). This was similarly the case for their respective lysine-augmented mutants, highlighting a fundamental difference in activity between the genomic and ICE-encoded toxins.
Structural analysis of TfiT
To explore the impact of the C-terminal lysines on the structure of TifT we generated a homology model of TfiT using the structure of the related HP0894 toxin as template (PDB: 4LTT). Superposition of the TfiT homology model, initially with the structure of H. pylori HP0894 showed good correspondence and global maintenance of secondary structural elements (Supplementary Fig. S7), and together with HP0892 (PDB: 4NRN) confirmed the spatial conservation of key catalytic residues within the active site between all three molecules (Fig. 6a, left). In particular, the putative catalytic triad comprising E58/R82/H86 of HP0892 and E58/R80/H84 of HP089424 is equally well-conserved in TfiT (E59/R83/H87) (Fig. 6a). The conserved Glu residue of the triad acts as a general base with His as a general acid in the acid–base catalysis reaction whereas Arg is involved in phosphate binding and stabilisation of the transition state26,27. In addition to these critical catalytic residues, aromatic side-chains of highly conserved Phe/Tyr residues in the extreme C-terminus of the toxins, including Phe88 in HP0894, Phe90 of HP0892, Phe91 of YafQ, and Tyr87 of RelE are involved in substrate orientation and facilitate the acid–base catalysis reaction23,26,27,43. The sequence and structural conservation of equivalent TfiT residues, including Phe91 (Fig. 6a right) suggests they are also likely to contribute to catalysis in these respects.
In the immediate context of these catalytic residues, the lysine doublet of TfiT appears to form an extension of the α3-helix relative to the C-terminus of HP0892 and HP0894, where their disposition on the helical turn locates them on the face of the molecule adjacent to the conserved Arg83 (Fig. 6a, right). In an electrostatic surface representation of the modelled TfiT structure it is apparent that whereas the presence of the lysines generally extends the surface area in the immediate vicinity of the active site, their basic side-chains also contribute to an increase in the local positive electrostatic environment (Fig. 6b). This might therefore provide a larger surface and increased attractive force for substrate interaction similar to the RelE model of catalysis, whereby electrostatic forces from basic side chains are proposed to draw mRNA substrate into the active site binding pocket43.
Discussion
In this report, we have found Type II toxin–antitoxin systems of the DinJ-YafQ family to be widespread amongst diverse genera of bacteria and frequently occurring in a multiplicity of strain and species-specific subtypes. In H. pylori, six distinct subtypes can be identified, four of which are novel and not identified in a previous survey of Type II TA loci29. All six TA loci have the capacity for host chromosome integration, although two, represented by Clades T4/AT4 and T6/AT6, are commonly found on H. pylori plasmids and can presumably readily mobilise between strains. Interestingly, homologous T4/AT4 module sequences are also apparent on small WGS contigs of four S. pseudintermedius strains (Supplementary Fig. S1B) which also include sequences of two other hypothetical proteins similarly common to H. pylori plasmids. The high level of identity between these common sequences suggests a recent and hitherto unappreciated inter-species transfer of the encoding plasmids although the dynamics of such an interaction remains unclear since neither H. pylori nor S. pseudintermedius, a common skin inhabitant of domestic cats and dogs44, are known to reciprocally colonise the other’s host.
Surprising, the plasmid-associated TAs appeared inactive in nearly half of all strains in which they occurred due to the absence or mutation of the toxin gene. Possibly, this reflected a toxin-independent function of antitoxin as previously suggested for DinJ45, or some functional redundancy as a consequence of host integration of the TA module rather than a dispensable plasmid function. However, this could not be readily determined due to the often limited sequence context available from short encoding WGS contigs. In contrast, we found the TA module encoded by the tfs4 ICE to be invariably intact and ancestrally conserved, arguing for an ongoing requirement specifically for the Clade T3/AT3 TA module in tfs4 ICE function. However, that the TA module is often absent in remnant tfs4 ICEs38,46 suggests that the TA system does not prevent ICE decay during long periods of stable integration. Indeed, acquisition/exchange, loss and degeneration of functional modules is a feature of ICE evolution47 which is similarly observed for tfs4 in many H. pylori strains38,46. Our collective results determine that the characteristics and broad activity of TfiA and TfiT are consistent with features of the prototypical E. coli DinJ-YafQ TA system and both the HP0892/HP0893 and HP0894/HP0895 chromosomal TA pairs of H. pylori18,24,25. Most notably, (i) both genes overlap in a bicistron and characteristically encode acidic (TfiA) and basic (TfiT) small proteins which (ii) are phylogenetically related to the DinJ-YafQ family of Type II TA systems, (iii) TfiT strongly inhibits bacterial growth, (iv) TfiT-mediated growth arrest can be both inhibited and rescued in the presence of TfiA, (v) TfiA and TfiT specifically and stably interact together and (vi) TfiT has cation-dependent ribonuclease activity which (vii) requires a highly conserved C-terminal active site His residue, typical of YafQ-family toxins, for catalysis. In addition, the ability of TfiA-TfiT to maintain a constitutively extrachromosomal element (i.e. plasmid) from host loss in vivo further suggests that the ICE TA may confer an important stability function in respect of tfs4 consistent with observations for other ICE TAs40,48 and tfs4 itself49. However, although TfiA-TfiT are conventional in these respects several aspects of TfiT activity are distinctive. In particular, in addition to RNase activity, we also found the substrate range of TfiT to unexpectedly extend to DNA.
In a plasmid model, our cleavage assays clearly delineated a progressive nicking relaxation, linearization and comprehensive fragmentation of supercoiled plasmid suggesting that TfiT possesses both nicking endonuclease and RNase activities. Endonuclease activity was uniquely also demonstrated towards genomic DNA and both RNase/DNase activity could be abrogated by mutation or deletion of key C-terminal catalytic residues comprising the ‘HSELF’ motif. As these residues contribute to both generation of the active site binding pocket and catalysis in other YafQ-like toxins and the modelled TfiT, it can be considered that binding and catalysis of both RNA and DNA substrates occurs at the same or spatially close sites, consistent with other sugar non-specific nucleases50,51. Non-typical Type II toxins with DNA nicking endonuclease activity have been reported amongst the RelE/ParE toxin superfamily, most notably Vp1843 of Vibrio parahaemolyticus52. Similarly, the RalR toxin of the RalR/RalA Type I TA system functions as a non-specific endonuclease similar to DNase I53. Neither protein however shares sequence features or the substrate range of TfiT, although as nuclease toxins, both also appear to be rapidly inhibitory of bacterial cell growth.
Of particular note in this study, we determined that the C-terminal Lys91/Lys92 doublet peculiar to TfiT conferred a remarkable potentiation of its activity. The particular disposition of the lysine side-chains immediately proximal to the active site presents a highly basic surface which is likely to increase recruitment, presentation and subsequent catalysis of nucleic acid substrates. Neubauer et al. proposed a similar role for basic side-chains in the vicinity of the active site in a model of RelE catalysis43. It has also been established that lysine repeats in the C-terminus of enzymes such as topoisomerase I (TopA) are essential for DNA binding and enable high enzyme processivity through stabilisation of the DNA-enzyme complex54. The marked increase in RNase activity we observed with the lysine-augmented HP0892 toxin in particular suggests this may similarly be the case for TfiT and would account for its rapid and potent toxicity. In the context of the tfs4 ICE, this might be required to provide a rapid safeguard against ICE loss following transient periods of ICE excision.
However, other determinants of substrate specificity presumably direct subsequent substrate recognition since neither HP0892KK nor HP0894KK toxins were also found to be catalytically active towards genomic DNA in our in vitro assays. In this respect, extended basic patches on the surface of E. coli YafQ and HP0894, comprising lysine residues Lys50, Lys52 and Lys54 are recognised to be particularly important for substrate interactions19,25,26, although are not especially well-conserved between other YafQ-family members, including TfiT (comprising Ser51, Asn53, Lys55 in equivalent positions) (Fig. 4). Therefore, the particular distribution of lysines is likely to introduce variability in the electrostatic surface of different toxins, as indicated in the electrostatic surface representation of the H. pylori YafQ toxins (Fig. 6b), which directly impacts binding and specific presentation of substrate at the active site.
Whilst TfiT is the only H. pylori YafQ-family subtype with a C-terminal lysine extension it is noteworthy that single or double lysines, in addition to a range of other residues with different charge and side-chain properties are also a common terminal feature of YafQ toxins in many other bacteria (Fig. 4c, Supplementary File S1). The findings of the present study suggest that these could similarly impact substrate interactions at the active site and may provide a common mechanism for precise functional modulation of toxin activity relative to different physiological roles of particular species-adapted YafQ-family TA systems.
Methods
Microbial strains and culture conditions
Strains used are listed in Supplementary Table S1. H. pylori strains were cultured with minimal passage on 5% (v/v) horse blood agar plates (Oxoid) at 37 °C in a microaerophilic atmosphere. E. coli strains were grown at 37 °C in Luria Broth (LB) or agar (Oxoid), supplemented with ampicillin (50–100 µg ml−1), kanamycin (50 µg ml−1), chloramphenicol (35 µg ml−1), l-arabinose (0.02% w/v) or isopropyl-β-d-thiogalactopyranoside (IPTG, 1 mM) as required. Saccharomyces cerevisiae was maintained in SC medium supplemented with 2% glucose (w/v) at 30 °C.
Generation of recombinant plasmid constructs
Plasmids and constructs are listed in Supplementary Table S2. Genomic DNA was prepared from H. pylori strains using the GenElute Bacterial Genomic DNA kit (Sigma-Aldrich). Toxin, antitoxin and TA module sequences were PCR-amplified using Phusion DNA polymerase (New England BioLabs) using oligonucleotide primers (Sigma-Aldrich) listed in Supplementary Table S3. PCR products were restricted with NcoI/EcoRI, SacI/SalI or EcoRI/SalI for subsequent ligation into corresponding sites of the pBAD/myc-His, pUC18 or pGAD424/pGBT9 yeast-two hybrid vectors respectively. tfiA was ligated into NdeI/XhoI sites of the MCS2 of pACYCDuet-1 for fusion to the S-tag sequence (encoding the epitope KETAAAKFERQHMDS) and the entire TA module inserted across both MCS1/MCS2 of pACYCDuet-1 using BamHI/XhoI enzymes, enabling concomitant fusion of tfiT and tfiA with His6-tag and S-tag sequences respectively. Constructs were transformed to BL21(DE3) pLysS or SoluBL21 for overexpression of recombinant protein or additionally, MG1655 and BW25113 strains for assessment of phenotypic effects. All constructs were confirmed by DNA sequencing (Source BioScience).
Toxicity and recovery assay
Cultures containing recombinant pBAD/myc-His plasmids were induced with 0.02% (w/v) l-arabinose at an optical density (OD600) of ~ 0.3. Samples taken at time-points were serially diluted then plated in triplicate on LB agar plates (± 100 µg ml−1 ampicillin) for calculation of colony forming units (CFU ml−1). Experiments involving pACYC-Duet-1 constructs in either BL21(DE3) pLysS or SoluBL21 were performed in the same way following IPTG (1 mM) induction. For recovery assays, cultures of SoluBL21 co-transformed with both pBAD-tfiT and pACYCDuet-tfiA constructs were induced with 0.02% (w/v) l-arabinose for 3 h, then diluted samples plated in triplicate on selective LB agar with or without IPTG (1 mM) prior to calculation of CFU ml−1 after 16 h incubation.
Plasmid stability assay
A single colony of E. coli MG1655 containing pUC18, pUC18-F0, pUC18-F1 or pUC18-F2 was inoculated into 10 ml of LB broth without antibiotic then cultures passaged 1:2,000 every 24 h for 8–10 passages. At each passage, a 1,000,000 × dilution of overnight culture was also prepared and 75 µl spread onto LB agar plates without antibiotic. Plates were incubated at 37 °C overnight then replica-plated to fresh LB agar plates (± 100 µg ml−1 ampicillin). Following overnight incubation, the number of colonies on the selective plates were expressed as a percentage of total colonies on the non-selective plates as a measure of plasmid maintenance.
Purification of recombinant toxins
Cultures of SoluBL21 containing pBAD/myc-His toxin constructs were grown to an OD600 of 0.6–0.7 prior to addition of 0.02% (w/v) l-arabinose for 3 h. Harvested cells were lysed by sonication in binding buffer containing 20 mM Tris–HCl pH 7.0, 200 mM NaCl, 5 mM imidazole and 1X protease inhibitors (Roche) using a Soniprep 150 sonicator (Sanyo). Lysates were centrifuged at 10,000×g, 0.45 µm-filtered, then incubated with TALON metal affinity resin (Clontech) for 1 h at 4 °C, prior to loading in gravity-flow columns. His-tagged proteins were eluted using binding buffer containing 300 mM imidazole. Elution fractions were immediately concentrated and buffer exchanged into storage buffer (25 mM Tris–HCl pH 7.5) using Vivaspin centrifugal concentrators (Sartorius Ltd) and stored at − 80 °C. Protein purity was estimated to be > 95% for all purified proteins by SDS-PAGE and protein concentrations determined using the BCA assay (Pierce).
Pull-down assay and far western
Clarified lysate containing His-tagged protein was immobilised on TALON metal affinity resin (Clontech) prior to addition of lysate containing S-tagged protein. Following a comprehensive wash step, immobilised proteins were eluted in binding buffer containing 300 mM imidazole then samples resolved by 15% SDS-PAGE prior to Western blotting. Blocked blots were probed with either anti-His6 antibody (Novagen) or anti-S-tag antibody (ThermoFisher Scientific), then alkaline phosphatase-conjugated secondary antibody (Sigma-Aldrich) prior to signal detection using 5-bromo-4-chloro-3indolyl phosphate/nitro blue tetrazolium liquid substrate (Sigma-Aldrich). For Far Western assays, lysates containing S-tagged antitoxin were resolved by SDS-PAGE prior to transfer to nitrocellulose by Western blotting. Blocked blots were probed with purified His-tagged toxin protein (0.12 µg ml−1) overnight at 4 °C, washed, then probed with either anti-His6 antibody (Novagen) or anti-S-tag antibody and developed for signal detection as before.
Yeast two-hybrid assay
Relevant pGBT9 and pGAD424 constructs (20 µl each) were co-transformed into S. cerevisiae strain PJ69-4A using the high efficiency lithium acetate transformation procedure55. Co-transformants were initially selected by plating on yeast minimal medium (YMM) supplemented with 2% glucose (w/v) plus methionine (20 µg ml−1), uracil (20 µg ml−1), histidine (20 µg ml−1), and adenine (20 µg ml−1) (MUHA plates) and then subsequently replica-plated onto YMM lacking either histidine (MUA) or both histidine and adenine (MU plates) to select for activation of the HIS3/ADE2 reporters. Quantitative assessment of β-galactosidase activity in cell extracts of PJ69-4A cell was made using o-nitrophenyl-β-d galactopyranoside as substrate56.
Nucleic acids and cleavage assays
Dilutions of purified toxin (0–16 µM) were incubated with mRNA (100 ng), pGEM-TEasy plasmid (50 ng) and genomic DNA from H. pylori strain P12 (100 ng) in reaction buffer (20 mM Tris–HCl pH 7.0, 50 mM NaCl, 2.5 mM MgSO4) for 30 min at 37 °C. Reactions were quenched by addition of 6 × purple loading dye (New England BioLabs) then analysed by electrophoresis on 0.8% agarose gels stained with ethidium bromide. Purified NcoI-restricted linear plasmid DNA (30 ng) was optionally included as a size marker. Reaction buffer was also prepared with 2.5 mM of each of MgCl2, MnCl2, CuCl2, ZnCl2, NiCl2 and CaCl2 as required.
Relevant templates were prepared using the GenElute Bacterial Genomic DNA kit (Sigma-Aldrich), Nucleospin Plasmid DNA purification kit (Macherey–Nagel) or RNeasy Plus Mini kit (Qiagen) as appropriate. Messenger RNA was transcribed in vitro from PCR-amplified recA or tfiT template using the HiScribe T7 Quick High Yield RNA Synthesis kit (New England BioLabs). The quality and concentration of DNA and RNA samples was monitored with a Nanodrop spectrophotometer (Thermo Scientific).
Nick-site determination
Purified genomic DNA (250 ng) from H. pylori strain P12 was incubated with TfiT toxin (16 µM) in reaction buffer (20 mM Tris–HCl pH 7.0, 50 mM NaCl, 2.5 mM MgSO4) for 30 min at 37 °C. Cleaved products were purified, then A-tailed by incubation with 0.2 mM dATP and 5U Taq DNA polymerase (New England BioLabs) at 70 °C for 20 min. The modified products were ligated with pGEM-TEasy then transformed into E. coli XLI-Blue. Plasmid DNA was isolated from 30 transformant colonies, inserts sequenced (Source BioScience), then sequences searched against the P12 genome sequence to determine orientation, flanking sequence context and precise cleavage site at both insert ends. The sequence 10 bp either side of the cleavage site was determined for each insert end, then all 20mers aligned using Clustal Omega. WebLogo57 was used to determine positional sequence conservation of aligned sequence subsets.
Generation and analysis of datasets
Toxin and antitoxin sequences were retrieved from the NCBI non-redundant sequence database following BLASTp searches using default parameters (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Subject sequences were depleted of major truncates using the BioEdit Sequence Editor58, then multiple sequence alignments performed using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) for derivation of initial toxin and antitoxin sequence subsets. Promotor sites were predicted using the Softberry BPROM service (https://www.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb).
For TA module prevalence, representative TA sequences were used in sequential BLASTp searches of the Helicobacteraceae database within the PATRIC bioinformatics platform59. Subject hits were assigned to TA module subsets based on percentage identity cutoff (> 85% identity) and confidence scores, then sorted by PATRIC genome identifier to determine TA module representation within individual strain genomes. WebLogo57 was used to determine positional sequence conservation of the final aligned sequence subsets. Gene content matrices representing the prevalence of YafQ-family toxin–antitoxin genes in H. pylori genomes were built in R(v3.2.2)60 using the ‘gplots’ package61. Hierarchical clustering of loci used the ‘hclust’ function (ward.D2 method and Euclidean distance measure) to generate a sidelong dendrogram.
Phylogenetic analyses
Sequences aligned with ClustalW or MUSCLE were used for generation of phylogenetic trees in MEGA X62. The evolutionary history was inferred using the Maximum Likelihood method and Tamura 3-parameter model with 1,000 bootstrap replicates. A discrete Gamma distribution was used to model evolutionary rate differences among sites.
Homology modelling
Homology modelling of HPP12_0453 (TfiT) used the PyMod 2.0 plugin module for PyMol63,64 as a convenient interface to Modeller 9v465. The H. pylori HP0894 structure (PDB: 4LTT) was used for primary alignment as the highest scoring template. Output models with corresponding low scoring Discrete Optimised Protein Energy (DOPE) profiles were manually inspected for agreement with secondary structural elements then assessed using PROCHECK66 and ERRAT67 prior to final model selection. Surface electrostatics were calculated using APBS and pdb2pqr from within PyMol68,69.
Supplementary information
Acknowledgements
We thank Karen Bunting for contributing to structural analysis and for assistance with the preparation of PYMOL Figures.
Author contributions
R.M.D. conceived and designed the study. R.M.D. performed bioinformatics analyses. K.B., S.L.S and R.M.D. performed experiments. R.M.D. wrote the paper. All authors reviewed results, revised and approved the final version of the manuscript.
Funding
This work was supported by Nottingham Hospitals Charity [PP-R Delahay-Nov 14 to R.M.D]. Funding for publication fees: National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre.
Data availability
Additional datasets generated during the current study are available from the corresponding author.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-020-72063-x.
References
- 1.Pandey DP, Gerdes K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 2005;33:966–976. doi: 10.1093/nar/gki201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gerdes K, Rasmussen PB, Molin S. Unique Type of plasmid maintenance function: Postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. U.S.A. 1986;83:3116–3120. doi: 10.1073/pnas.83.10.3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lehnherr H, Maguin E, Jafri S, Yarmolinsky MB. Plasmid addiction genes of bacteriophage P1: Doc, which causes cell death on curing of prophage, and phd, which prevents host death when prophage is retained. J. Mol. Biol. 1993;233:414–428. doi: 10.1006/jmbi.1993.1521. [DOI] [PubMed] [Google Scholar]
- 4.Chopra N, Saumitra PA, Bhatnagar R, Bhatnagar S. Linkage, mobility, and selfishness in the MazF family of bacterial toxins: A snapshot of bacterial evolution. Genome Biol. Evol. 2013;5:2268–2284. doi: 10.1093/gbe/evt175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Hazan R, Engelberg-Kulka H. Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1. Mol. Genet. Genomics. 2004;272:227–234. doi: 10.1007/s00438-004-1048-y. [DOI] [PubMed] [Google Scholar]
- 6.Fineran PC, et al. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin–antitoxin pair. Proc. Natl. Acad. Sci. U.S.A. 2009;106:894–899. doi: 10.1073/pnas.0808832106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang X, et al. Antitoxin MqsA helps mediate the bacterial general stress response. Nat. Chem. Biol. 2011;7:359–366. doi: 10.1038/nchembio.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wang X, Wood TK. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl. Environ. Microbiol. 2011;77:5577–5583. doi: 10.1128/AEM.05068-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wen Y, Behiels E, Devreese B. Toxin-Antitoxin systems: Their role in persistence, biofilm formation, and pathogenicity. Pathog. Dis. 2014;70:240–249. doi: 10.1111/2049-632X.12145. [DOI] [PubMed] [Google Scholar]
- 10.Kedzierska B, Hayes F. Emerging roles of toxin–antitoxin modules in bacterial pathogenesis. Molecules. 2016 doi: 10.3390/molecules21060790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lobato-Marquez D, Moreno-Cordoba I, Figueroa V, Diaz-Orejas R, Garcia-del Portillo F. Distinct Type I and Type II toxin–antitoxin modules control Salmonella lifestyle inside eukaryotic cells. Sci. Rep. 2015;5:9374. doi: 10.1038/srep09374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Page R, Peti W. Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat. Chem. Biol. 2016;12:208–214. doi: 10.1038/nchembio.2044. [DOI] [PubMed] [Google Scholar]
- 13.Marimon O, et al. An oxygen-sensitive toxin–antitoxin system. Nat. Commun. 2016;7:13634. doi: 10.1038/ncomms13634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Makarova KS, Wolf YI, Koonin EV. Comprehensive comparative-genomic analysis of Type 2 toxin–antitoxin systems and related mobile stress response systems in prokaryotes. Biol. Direct. 2009;4:19. doi: 10.1186/1745-6150-4-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Leplae R, et al. Diversity of bacterial Type II toxin–antitoxin systems: A comprehensive search and functional analysis of novel families. Nucleic Acids Res. 2011;39:5513–5525. doi: 10.1093/nar/gkr131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jiang Y, Pogliano J, Helinski DR, Konieczny I. ParE toxin encoded by the broad-host-range plasmid RK2 is an inhibitor of Escherichia coli gyrase. Mol. Microbiol. 2002;44:971–979. doi: 10.1046/j.1365-2958.2002.02921.x. [DOI] [PubMed] [Google Scholar]
- 17.Motiejunaite R, Armalyte J, Markuckas A, Suziedeliene E. Escherichia coli dinJ-yafQ genes act as a toxin–antitoxin module. FEMS Microbiol. Lett. 2007;268:112–119. doi: 10.1111/j.1574-6968.2006.00563.x. [DOI] [PubMed] [Google Scholar]
- 18.Prysak MH, et al. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol. Microbiol. 2009;71:1071–1087. doi: 10.1111/j.1365-2958.2008.06572.x. [DOI] [PubMed] [Google Scholar]
- 19.Maehigashi T, Ruangprasert A, Miles SJ, Dunham CM. Molecular basis of ribosome recognition and mRNA hydrolysis by the E. coli YafQ toxin. Nucleic Acids Res. 2015;43:8002–8012. doi: 10.1093/nar/gkv791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pedersen K, et al. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell. 2003;112:131–140. doi: 10.1016/s0092-8674(02)01248-5. [DOI] [PubMed] [Google Scholar]
- 21.Yamaguchi Y, Park JH, Inouye M. MqsR, a crucial regulator for quorum sensing and biofilm formation, is a GCU-specific mRNA interferase in Escherichia coli. J. Biol. Chem. 2009;284:28746–28753. doi: 10.1074/jbc.M109.032904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cruz JW, et al. Doc toxin is a kinase that inactivates elongation factor Tu. J. Biol. Chem. 2014;289:7788–7798. doi: 10.1074/jbc.M113.544429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Armalyte J, Jurenaite M, Beinoraviciute G, Teiserskas J, Suziedeliene E. Characterization of Escherichia coli dinJ-yafQ toxin–antitoxin system using insights from mutagenesis data. J. Bacteriol. 2012;194:1523–1532. doi: 10.1128/JB.06104-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Han KD, et al. Identification of chromosomal HP0892-HP0893 toxin–antitoxin proteins in Helicobacter pylori and structural elucidation of their protein–protein interaction. J. Biol. Chem. 2013;288:6004–6013. doi: 10.1074/jbc.M111.322784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Han KD, et al. Functional identification of toxin–antitoxin molecules from Helicobacter pylori 26695 and structural elucidation of the molecular interactions. J. Biol. Chem. 2011;286:4842–4853. doi: 10.1074/jbc.M109.097840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pathak C, et al. Crystal structure of apo and copper bound HP0894 toxin from Helicobacter pylori 26695 and insight into mRNase activity. Biochim. Biophys. Acta. 1834;2579–2590:2013. doi: 10.1016/j.bbapap.2013.09.006. [DOI] [PubMed] [Google Scholar]
- 27.Im H, et al. Crystal structure of toxin HP0892 from Helicobacter pylori with two Zn(II) at 1.8 A resolution. Protein Sci. 2014;23:819–832. doi: 10.1002/pro.2465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kwon AR, et al. Structural and biochemical characterization of HP0315 from Helicobacter pylori as a VapD protein with an endoribonuclease activity. Nucleic Acids Res. 2012;40:4216–4228. doi: 10.1093/nar/gkr1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cardenas-Mondragon MG, et al. Transcriptional profiling of Type II toxin–antitoxin genes of Helicobacter pylori under different environmental conditions: Identification of HP0967-HP0968 system. Front. Microbiol. 2016;7:1872. doi: 10.3389/fmicb.2016.01872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Peek RM, Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer. 2002;2:28–37. doi: 10.1038/nrc703. [DOI] [PubMed] [Google Scholar]
- 31.Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863–1873. doi: 10.1053/j.gastro.2009.01.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Censini S, et al. cag, a pathogenicity island of Helicobacter pylori, encodes Type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. U.S.A. 1996;93:14648–14653. doi: 10.1073/pnas.93.25.14648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bridge DR, Merrell DS. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes. 2013;4:101–117. doi: 10.4161/gmic.23797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An overview of Helicobacter pylori VacA toxin biology. Toxins (Basel) 2016 doi: 10.3390/toxins8060173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005;128:833–848. doi: 10.1053/j.gastro.2005.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sugimoto M, Watada M, Jung SW, Graham DY, Yamaoka Y. Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J. Clin. Microbiol. 2012;50:441–448. doi: 10.1128/JCM.00906-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Alandiyjany MN, Croxall NJ, Grove JI, Delahay RM. A role for the tfs3 ICE-encoded Type IV secretion system in pro-inflammatory signalling by the Helicobacter pylori Ser/Thr kinase, CtkA. PLoS ONE. 2017;12:e0182144. doi: 10.1371/journal.pone.0182144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Delahay RM, Croxall NJ, Stephens AD. Phylogeographic diversity and mosaicism of the Helicobacter pylori tfs integrative and conjugative elements. Mob. DNA. 2018;9:5. doi: 10.1186/s13100-018-0109-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wozniak RA, Waldor MK. Integrative and conjugative elements: Mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat. Rev. Microbiol. 2010;8:552–563. doi: 10.1038/nrmicro2382. [DOI] [PubMed] [Google Scholar]
- 40.Wozniak RA, Waldor MK. A toxin–antitoxin system promotes the maintenance of an integrative conjugative element. PLoS Genet. 2009;5:e1000439. doi: 10.1371/journal.pgen.1000439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Blower TR, Salmond GP, Luisi BF. Balancing at survival's edge: The structure and adaptive benefits of prokaryotic toxin–antitoxin partners. Curr. Opin. Struct. Biol. 2011;21:109–118. doi: 10.1016/j.sbi.2010.10.009. [DOI] [PubMed] [Google Scholar]
- 42.Liang Y, et al. Structural and functional characterization of Escherichia coli toxin–antitoxin complex DinJ-YafQ. J. Biol. Chem. 2014;289:21191–21202. doi: 10.1074/jbc.M114.559773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Neubauer C, et al. The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE. Cell. 2009;139:1084–1095. doi: 10.1016/j.cell.2009.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Grandolfo E. Looking through Staphylococcus pseudintermedius infections: Could SpA be considered a possible vaccine target? Virulence. 2018;9:703–706. doi: 10.1080/21505594.2018.1426964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hu Y, Benedik MJ, Wood TK. Antitoxin DinJ influences the general stress response through transcript stabilizer CspE. Environ. Microbiol. 2012;14:669–679. doi: 10.1111/j.1462-2920.2011.02618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Fischer W, et al. A comprehensive analysis of Helicobacter pylori plasticity zones reveals that they are integrating conjugative elements with intermediate integration specificity. BMC Genomics. 2014;15:310. doi: 10.1186/1471-2164-15-310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bellanger X, Payot S, Leblond-Bourget N, Guedon G. Conjugative and mobilizable genomic islands in bacteria: Evolution and diversity. FEMS Microbiol. Rev. 2014;38:720–760. doi: 10.1111/1574-6976.12058. [DOI] [PubMed] [Google Scholar]
- 48.Huguet KT, Gonnet M, Doublet B, Cloeckaert A. A toxin antitoxin system promotes the maintenance of the IncA/C-mobilizable Salmonella Genomic Island 1. Sci. Rep. 2016;6:32285. doi: 10.1038/srep32285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Fischer W, et al. Strain-specific genes of Helicobacter pylori: Genome evolution driven by a novel Type IV secretion system and genomic island transfer. Nucleic Acids Res. 2010;38:6089–6101. doi: 10.1093/nar/gkq378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Rangarajan ES, Shankar V. Sugar non-specific endonucleases. FEMS Microbiol. Rev. 2001;25:583–613. doi: 10.1111/j.1574-6976.2001.tb00593.x. [DOI] [PubMed] [Google Scholar]
- 51.Lee KY, et al. Structure-based functional identification of Helicobacter pylori HP0268 as a nuclease with both DNA nicking and RNase activities. Nucleic Acids Res. 2015;43:5194–5207. doi: 10.1093/nar/gkv348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Zhang J, Ito H, Hino M, Kimura M. A RelE/ParE superfamily toxin in Vibrio parahaemolyticus has DNA nicking endonuclease activity. Biochem. Biophys. Res. Commun. 2017;489:29–34. doi: 10.1016/j.bbrc.2017.05.105. [DOI] [PubMed] [Google Scholar]
- 53.Guo Y, et al. RalR (a DNase) and RalA (a small RNA) form a Type I toxin–antitoxin system in Escherichia coli. Nucleic Acids Res. 2014;42:6448–6462. doi: 10.1093/nar/gku279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Strzalka A, Szafran MJ, Strick T, Jakimowicz D. C-terminal lysine repeats in Streptomyces topoisomerase I stabilize the enzyme-DNA complex and confer high enzyme processivity. Nucleic Acids Res. 2017;45:11908–11924. doi: 10.1093/nar/gkx827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Gietz RD, Schiestl RH, Willems AR, Woods RA. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast. 1995;11:355–360. doi: 10.1002/yea.320110408. [DOI] [PubMed] [Google Scholar]
- 56.Zubay G, Morse DE, Schrenk WJ, Miller JH. Detection and isolation of the repressor protein for the tryptophan operon of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1972;69:1100–1103. doi: 10.1073/pnas.69.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: A sequence logo generator. Genome Res. 2004;14:1188–1190. doi: 10.1101/gr.849004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999;41:95–98. [Google Scholar]
- 59.Wattam AR, et al. Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center. Nucleic Acids Res. 2017;45:D535–D542. doi: 10.1093/nar/gkw1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Team, R. C. R: A language and environment for statistical computing. R R Foundation for Statistical Computing, Vienna, Austria (2016).
- 61.61Warnes, G. R. B., et al. gplots: Various R Programming Tools for Plotting Data. R package version 3.0.1 (2016).
- 62.Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 2018;35:1547–1549. doi: 10.1093/molbev/msy096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Janson G, Zhang C, Prado MG, Paiardini A. PyMod 2.0: Improvements in protein sequence-structure analysis and homology modeling within PyMOL. Bioinformatics. 2017;33:444–446. doi: 10.1093/bioinformatics/btw638. [DOI] [PubMed] [Google Scholar]
- 64.The PyMOL Molecular Graphics System, V., Schrödinger, LLC.
- 65.Webb B, Sali A. protein structure modeling with MODELLER. Methods Mol. Biol. 2017;1654:39–54. doi: 10.1007/978-1-4939-7231-9_4. [DOI] [PubMed] [Google Scholar]
- 66.Laskowski RAM, Moss DS, Thronton JM. PROCHECK—A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993;26:283–291. doi: 10.1107/S0021889892009944. [DOI] [Google Scholar]
- 67.Colovos C, Yeates TO. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 1993;2:1511–1519. doi: 10.1002/pro.5560020916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Jurrus E, et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 2018;27:112–128. doi: 10.1002/pro.3280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA. PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 2004;32:W665–667. doi: 10.1093/nar/gkh381. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Additional datasets generated during the current study are available from the corresponding author.